Skip to main content
Premium Trial:

Request an Annual Quote

Protein Forest Closes $19M Series A

NEW YORK, Nov. 21 (GenomeWeb News) - Proteomics separations start-up ProteinForest announced today that it has closed a $19 million Series A financing.


The Watertown, Mass.-based company's technology consists of a suite of products centered around the ProteomeChip - developed by three Israeli physicists - which the company claims can separate and image all proteins in a biological sample in one hour or less, with high sensitivity, reproducibility, and accuracy. The company is currently led by CEO Russell Garlick, former vice president of R&D at PerkinElmer.


S.R. One, Boston Millennia Partners, IDG Venture, and Novo A/S led the Series A financing.


The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.